These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2553078)

  • 21. Correlation of DNA flow cytometry and hormone receptors with axillary lymph node status in patients with carcinoma of the breast.
    Friedman NS; Freedman MD
    Md Med J; 1994 Nov; 43(11):963-5. PubMed ID: 7808198
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prediction of additional axillary metastasis of breast cancer following sentinel lymph node surgery.
    Changsri C; Prakash S; Sandweiss L; Bose S
    Breast J; 2004; 10(5):392-7. PubMed ID: 15327491
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation of clinical, pathological status, hormone receptor and C-erbB-2 oncoprotein in breast cancer patients.
    Aryandono T; Harijadi ; Ghozali A
    Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():600-6. PubMed ID: 10895217
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Axillary lymph node dissection in pT1 breast cancer: a retrospective analysis of 315 patients and review of the literature.
    Witt A; Obwegeser R; Auerbach L; Tempfer C; Yavuz D; Kubista E
    Wien Klin Wochenschr; 2002 Jun; 114(10-11):387-90. PubMed ID: 12708092
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estrogen and progesterone receptors in breast cancer: relationships to tumour histopathology and survival of patients.
    Blanco G; Alavaikko M; Ojala A; Collan Y; Heikkinen M; Hietanen T; Aine R; Taskinen PJ
    Anticancer Res; 1984; 4(6):383-9. PubMed ID: 6097159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FOXA1 expression in breast cancer--correlation with luminal subtype A and survival.
    Badve S; Turbin D; Thorat MA; Morimiya A; Nielsen TO; Perou CM; Dunn S; Huntsman DG; Nakshatri H
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4415-21. PubMed ID: 17671124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance.
    Arpino G; Weiss H; Lee AV; Schiff R; De Placido S; Osborne CK; Elledge RM
    J Natl Cancer Inst; 2005 Sep; 97(17):1254-61. PubMed ID: 16145046
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic significance of fibrotic focus in invasive ductal carcinoma of the breast: a prospective observational study.
    Hasebe T; Sasaki S; Imoto S; Mukai K; Yokose T; Ochiai A
    Mod Pathol; 2002 May; 15(5):502-16. PubMed ID: 12011255
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of low nm23 RNA levels in human primary infiltrating ductal breast carcinomas with lymph node involvement and other histopathological indicators of high metastatic potential.
    Bevilacqua G; Sobel ME; Liotta LA; Steeg PS
    Cancer Res; 1989 Sep; 49(18):5185-90. PubMed ID: 2475243
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estrogen and progesterone receptors in primary eccrine carcinoma.
    Voytek TM; Ricci A; Cartun RW
    Mod Pathol; 1991 Sep; 4(5):582-5. PubMed ID: 1661896
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ki-67 expression in axillary lymph node metastases in breast cancer is prognostically significant.
    Tawfik K; Kimler BF; Davis MK; Fan F; Tawfik O
    Hum Pathol; 2013 Jan; 44(1):39-46. PubMed ID: 22939959
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vimentin--a new prognostic parameter in breast carcinoma?
    Raymond WA; Leong AS
    J Pathol; 1989 Jun; 158(2):107-14. PubMed ID: 2547048
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship between progesterone receptor and productive fibrosis as an index of tumor differentiation in breast cancer.
    Giani C; Pinchera A; Breccia M; Campani D; De Negri F; Benigni G; Evangelista G; Miccoli P; Savarese MR; Incensati R
    Tumori; 1988 Jun; 74(3):287-93. PubMed ID: 2840763
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sodium iodide symporter, estrogen receptor, and progesterone receptor expression in carcinoma breast--an immunohistochemical analysis.
    Tandon A; Shrivastava A; Kumar A; Prayaga AK; Sundaram C; Godbole MM
    Indian J Pathol Microbiol; 2011; 54(4):745-51. PubMed ID: 22234102
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Breast cancer and the stromal factor. The "prometastatic healing process" hypothesis.
    Wernicke M; Roitman P; Manfre D; Stern R
    Medicina (B Aires); 2011; 71(1):15-21. PubMed ID: 21296715
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Morphologic and clinical aspects of estrogen receptors in carcinoma of the breast.
    Kern WH
    Surg Gynecol Obstet; 1979 Feb; 148(2):240-2. PubMed ID: 217114
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of the 323/A3 surface glycoprotein with tumor characteristics and behavior in human breast cancer.
    Tandon AK; Clark GM; Chamness GC; McGuire WL
    Cancer Res; 1990 Jun; 50(11):3317-21. PubMed ID: 2334924
    [TBL] [Abstract][Full Text] [Related]  

  • 38. EGF-R and steroid receptors in breast cancer: a comparison with tumor grading, tumor size, lymph node involvement, and age.
    Zeillinger R; Kury F; Speiser P; Sliutz G; Czerwenka K; Kubista E
    Clin Biochem; 1993 Jun; 26(3):221-7. PubMed ID: 8392451
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of tumor size and axillary lymph node metastasis on estrogen and progesterone receptors in primary breast cancer.
    Alghanem AA; Hussain S
    J Surg Oncol; 1986 Mar; 31(3):218-21. PubMed ID: 3724175
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Histopathological features and their association with steroid receptors in women with breast cancer in Fukuoka, Japan.
    Horie A; Nomura Y; Stemmermann GN; Catts A; Fukunaga FH; Shigematsu T; Hirohata T; Nomura AM
    Acta Pathol Jpn; 1984 Mar; 34(2):229-39. PubMed ID: 6331061
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.